###
中国临床研究英文版:2026,39(9):1334-1338,1344
本文二维码信息
码上扫一扫!
炎症-免疫-营养指标在乳腺癌预后中的研究进展
(1. 广东医科大学第一临床医学院,广东 湛江 524023;2. 广东医科大学附属医院血管甲状腺乳腺外科,广东 湛江 524023)
Advances in inflammation-immunity-nutrition indicators in prognosis of breast cancer
摘要
本文已被:浏览 253次   下载 193次
Received:June 14, 2026   Published Online:September 24, 2026
中文摘要: 乳腺癌是女性中发病率和死亡率最高的恶性肿瘤。随着筛查技术和综合治疗的不断进步,乳腺癌总体生存率有所提升,但不同分子分型和临床分期患者的预后差异仍然较大。大量研究表明,炎症、免疫与营养在肿瘤的发生、发展和转移中发挥了关键作用,并通过相互作用共同塑造肿瘤微环境。因此,炎症-免疫-营养相关指标可作为简便、经济的血液学工具,在一定程度上反映了肿瘤微环境状态,对乳腺癌患者的预后评估和治疗反应预测具有重要价值。本文就相关指标在乳腺癌预后中的研究进展进行综述,以期为乳腺癌的个体化治疗和精准预后评估提供参考。
Abstract:Breast cancer is the malignant tumor with the highest incidence and mortality rates among women. With continuous advancements in screening technologies and comprehensive treatment,the overall survival rate of breast cancer has improved.However, the prognosis still varies considerably among patients with different molecular subtypes and clinical stages. A large number of researches have shown that inflammation,immunity,and nutrition play crucial roles in the occurrence,progression,and metastasis of tumors,and jointly shape the tumor microenvironment through interaction. Therefore,inflammatory - immune - nutrition - related indicators can be used as a simple and cost-effective hematological tool to reflect the state of the tumor microenvironment to a certain extent,which is of great value for the prognosis assessment and prediction of treatment response in breast cancer patients. This article reviews the research progress of relevant indicators in the prognosis of breast cancer,aiming to provide references for personalized treatment and precise prognostic assessment of breast cancer.
文章编号:     中图分类号:R737.9    文献标志码:A
基金项目:广东省普通高校特色创新类项目(2021KTSCX037);新疆生产建设兵团科技计划项目 (2025DA068);北京微爱公益基金会菁医科研基金项目(JVⅡ2024-020122201);广东医科大学附属医院院内资助类临床研究项目(LCYJ2021B003)
引用文本:


Scan with WeChat

Scan with WeChat